Medifast announces the launch of the Medifast Metabolic Health Institute™, committed to advancing metabolic health through rigorous research and credible, evidence-based education.
Advancing metabolic health through
research and education
Built on decades of clinical research, our work is guided by a multidisciplinary team of scientists and experts in medical care, nutrition, exercise, biobehavioral science, and education.
Advancing metabolic health through
research and education
Built on decades of clinical research, our work is guided by a multidisciplinary team of scientists and experts in medical care, nutrition, exercise, biobehavioral science, and education.
Featured
Press Release
Nutrition 2026
Our Scientific & Clinical Affairs Team contributed four research poster presentations on their metabolic health research at the annual American Society for Nutrition conference.
NYSE Bell Ringing
First listed on the New York Stock Exchange in August 2006, Medifast returns to ring the bell at the NYSE, signaling a new era of metabolic health for Medifast.
Scientific Advisory
Learn more about our Scientific Advisory Board’s role in guiding evidence-based decisions, informing innovation, and translating complex science into actionable insights.
Backed by over 40 years of
scientific and clinical heritage
Medifast®, the company behind the Medifast Metabolic Health Institute, has a long-standing history of clinical research and scientific innovation, providing a robust foundation for our ongoing pursuit of scientific excellence.
NEW COACH TRAINING MODULE
Foundations of
Metabolic Synchronization®
Master the breakthrough science of Metabolic Synchronization and discover how the Trilivy™ Metabolic Health System is uniquely designed to support metabolic health and reverse metabolic dysfunction.* Learn how to act as a force multiplier, turning scientific breakthroughs into true metabolic health transformation.
*In a clinical study, individuals on the Trilivy Reset Plans experienced a reduction of 14% visceral fat and 97 to 98% of lean mass was retained at 16 weeks. Arterburn LM, Coleman CD, Kiel J, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. Feb 2019;5(1):3-14. doi:10.1002/osp4.312.
Committed to
scientific leadership
Explore highlights from our multidisciplinary team as they present clinical findings and share evidence-based insights at premier medical and nutrition conferences.
To view the full collection of posters presented by our team in 2025, please visit our dedicated research page.
© 2026 Medifast, Inc. All Rights Reserved.